Status:

TERMINATED

BTX-A Treatment for Palmar Hyperhidrosis

Lead Sponsor:

University of Wisconsin, Madison

Collaborating Sponsors:

Allergan

Mattioli

Conditions:

Primary Focal Hyperhidrosis of the Hands

Eligibility:

All Genders

16+ years

Phase:

PHASE2

PHASE3

Brief Summary

Primary focal hyperhidrosis (excessive sweating) is a debilitating condition affecting approximately 3% of the population in the United States. Not only that it is a major social embarrassment to affe...

Eligibility Criteria

Inclusion

  • Healthy male or non-pregnant female
  • Age 16 and older
  • If \<18, parent/legal guardian willing to sign consent and accompany to visits
  • Diagnosis of hyperhidrosis disease with a severity score (HDSS) of 3 or 4
  • Treatment types of topical antiperspirants, iontophoresis, or systemic anticholinergics have failed to treat
  • Able to come to 5 clinical visits during the study period

Exclusion

  • Diagnosis of neuromuscular disease such as peripheral motor neuropathic diseases (e.g. amyotrophic lateral sclerosis, or motor neuropathy)
  • Diagnosis of neuromuscular junctional disorders (e.g. myasthenia gravis or Lambert-Eaton syndrome)
  • Diagnosis of dysphagia
  • Individuals with surgical implants such as pacemakers, orthopedic hardware, etc.
  • Individuals who are Immunocompromised
  • Systemic infectious illness or infection at the injection site(s)
  • Known hypersensitivity to any ingredient in the formulation of the drug
  • Organic cause of hyperhidrosis
  • Known allergy to the ingredients in the general anesthesia
  • Diagnosis of cardiac/pulmonary issues or disease
  • Women who are pregnant or suspected to be pregnant

Key Trial Info

Start Date :

November 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2012

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT01262339

Start Date

November 1 2010

End Date

November 1 2012

Last Update

January 26 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin-Madison

Madison, Wisconsin, United States, 53716